Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 104, Issue 2, 2007, Pages 249-258

  Bianchi, Silvio Diego ^a   Scoletta, Matteo ^b   Cassione, Francesca Bozzalla ^a   Migliaretti, Giuseppe ^a   Mozzati, Marco ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b Oral Surgery Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

AGED; ARTICLE; BONE NECROSIS; BONE TUMOR; CHEMICALLY INDUCED DISORDER; CLUSTER ANALYSIS; COMPARATIVE STUDY; FEMALE; HUMAN; JAW DISEASE; MALE; METASTASIS; MIDDLE AGED; NONPARAMETRIC TEST; PANORAMIC RADIOGRAPHY; PATHOLOGY; RADIOGRAPHY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TOOTH EXTRACTION;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; CLUSTER ANALYSIS; DIPHOSPHONATES; FEMALE; HUMANS; JAW DISEASES; MALE; MIDDLE AGED; OSTEONECROSIS; RADIOGRAPHY, PANORAMIC; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, SPIRAL COMPUTED; TOOTH EXTRACTION;

EID: 34447259342     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2007.01.040     Document Type: Article

References (22)

1. Berenson J.R., Lichtenstein A., Porter L., Dimopoulos M.A., Bordoni R., George S., et al. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. N Engl J Med 334 (1996) 488-493
2. Hortobagyi G.N., Theriault R.L., Porter L., Blayney D., Lipton A., Sinoff C., et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. N Engl J Med 335 (1996) 1785-1791
3. Berenson J.R., Hillner B.E., Kyle R.A., Lpton A., Tee G.C., and Biermann J.S. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol 20 (2002) 3719-3736
4. Hillner B.E., Ingle J.N., Chlebowski R.T., Gralow J., Yee G.C., Janjan N.A., et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 21 (2003) 4042-4047
5. Brumsen C., Hamdy N.A., and Papapoulos S.E. Long-term effect of bisphosphonates on the growing skeleton: studies of young patients with severe osteoporosis. Medicine 76 (1997) 266-283
6. Devogelaer P. Treatment of bone diseases with bisphosphonates, excluding osteoporosis. Curr Opin Rheumatol 12 (2000) 331-335
7. Rodan G.A., and Fleisch H.A. Bosphosphonates: mechanisms of action. J Clin Invest 97 (1996) 2692-2696
8. Fournier P., Boissier S., Filleur S., Guglielmi J., Cabon F., Colombel M., et al. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 62 (2002) 6538-6544
9. Wang J., Goodger N.M., and Pogrel M.A. Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 61 (2003) 1104-1107
10. Migliorati C.A. Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 21 (2003) 4253-4254
11. Marx R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61 (2003) 1115-1117
12. Marx R.E., Sawatary Y., Fortin M., and Broumand V. Bisphosphonates-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention and treatment. J Oral Maxillofac Surg 63 (2005) 1567-1575
13. Greenberg M.S. Intravenous bisphosphonates and osteonecrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 (2004) 259-260
14. Ruggiero S.L., Mehrotra B., Rosenberg T.J., and Engroff S.L. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62 (2004) 527-534
15. Ruggiero S.L., Gralow J., Marx R.E., Hoff A.O., Schubert M.M., Huryn J.H., et al. Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract 2 (2006) 7-14
16. Ruggiero S.L., Fantasia J., and Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. J Oral Maxillofac Surg 102 (2006) 433-441
17. Fullmer J.M., Scarfe W.C., Kushner G.M., Alpert B., and Farman A.G. Cone beam computed tomographic findings in refractory chronic suppurative osteomyelitis of the mandible. Br J Oral Maxillofac Surg (2006) [Epub ahead of print].
18. Hellstein J.W., and Marek C.L. Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?. J Oral Maxillofac Surg 63 (2005) 682-689
19. Miles A.E.W. Phosphorous necrosis of the jaw: "phossy jaw.". Br Dent J 133 (1972) 203-206
20. Hansen T., Kunkel M., Weber A., and Kirkpatrik C.J. Osteonecrosis of the jaws in patients treated with bisphosphonates-histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 35 (2006) 155-160
21. Chiandussi S., Biasotto M., Dore F., Cavalli F., Cova M.A., and Di Lenarda R. Clinical and diagnostic imaging of bisphosphonates-associated osteonecrosis of the jaws. Dentomaxillofac Radiol 35 (2006) 236-243
22. Wutzl A., Eisenmenger G., Hoffmann M., Czerny C., Moser D., Pietschmann P., et al. Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients. Wien Klin Wochenschr 118 (2006) 473-478